<DOC>
	<DOCNO>NCT00237250</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness vildagliptin , unapproved drug , compare placebo lower post-meal blood glucose level people pre-diabetes high blood sugar level meal .</brief_summary>
	<brief_title>Efficacy Safety Vildagliptin Subjects With Impaired Glucose Tolerance</brief_title>
	<detailed_description />
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<criteria>Blood glucose criterion must meet Body mass index ( BMI ) range 2345 Diagnosis diabetes Serious cardiovascular event within past 6 month Use insulin oral antidiabetic agent Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Pre-diabetes</keyword>
	<keyword>vildagliptin</keyword>
	<keyword>IGT</keyword>
</DOC>